<DOC>
	<DOCNO>NCT02856802</DOCNO>
	<brief_summary>A safety efficacy DFN-02 , conduct multiple center United States .</brief_summary>
	<brief_title>An Efficacy Safety Study DFN-02</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>1 . A history episodic migraine experience average 2 8 migraine attack per month least past 12 month , 14 headache day per month , 48 hour headache free time migraine headache 2 . Patients migraine without aura . If migraine aura , aura last longer 60 minute . 3 . Patients willing able : 1 . Evaluate record pain , migraine symptom , study medication effectiveness information realtime use eDiary duration study ; 2 . Record instance use study medication rescue medication patient eDiary realtime duration study ; 3 . Comply study procedure schedule requirement . 1 . Minors , even specify study age range 2 . Medication overuse : 1 . Opioids ≥ 10 day 90 day prior screen 2 . Combination medication ( e.g. , Fiorinal® ) ≥ 10 day 90 day prior screen ( applies combination medication contain opioid and/or barbiturate ) 3 . Nonsteroidal Antiinflammatory Drugs simple medication ˃ 14 day month 90 day prior screen 4 . Triptans ergots ≥ 10 day month 90 day prior screen 3 . Treated onabotulinumtoxinA ( Botox® ) botulinum toxin treatment within 4 month prior screen migraine prophylaxis ( patient treat cosmetic purpose may allow casebycase basis approval Medical Monitor ) 4 . A history current neurological psychiatric impairment , cognitive dysfunction , opinion Investigator , would compromise data collection 5 . Use antipsychotic least 15 day prior randomization 6 . Patients receive treatment investigational drug device within 30 day prior randomization , within 3 month associate central nervous system 7 . Patients participated central nervous system clinical trial within 3 month prior randomization 8 . Patients test positive human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBsAg ) , hepatitis C virus ( HCV ) antibody serology test 9 . Patients employee immediate relative employee Sponsor , affiliate partner , clinical study research site</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>